NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment

Clinical trial NCT06537154 · RECRUITING

Trial details

NCT number: NCT06537154
Sponsor: Peter Black
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Muscle-Invasive Bladder Carcinoma

Start date: 2025-07-28
Primary completion: 2028-12-31
Enrollment: 688

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.